|
| | | |  A attestation of inspection was issued by EDQM & Healthcare on 11th January 2008. | | | The company was granted the GMP Certificate by Danish Medicines Agency in WHO foramt on 19 Dec 2007. The Certificate Number is 1720-48. | | | The company was granted the ISO 14001 Certificate on 2nd November 2007. The Certificate Number is 15/07E0565R00. | | | The company was granted the ISO 9001 Certificate on 2nd November 2007. The Certificate Number is 15/07Q0564R00. | | | DMF registration certificate of Ticlopidine HCl (JP) has been issued by the Ministry of Health, Labor ,and Welfare, Japan, on July 26, 2007. Certificate No.: 219MF10251. | | | March 22, 2007,granted “Accreditation of Foreign Manufacturer of Pharmaceuticals” by the Minister of Health, Labour and Welfare. Certificate No.: AG10500132. | | | Imiquimod DMF DMF No.: 20256, submitted on 28 January 2007. | | | 1-(3-hydroxymethylpyridyl-2)-2-phenyl-4-methylpiperazine (M3 Intermediate for Mirtazapine) DMF No.: 20150, submitted on 9 January 2007. | | | A COS issued by EDQM on July 7, 2006. Certificate No.: RO-CEP 2004-109-Rev 00. Name of substance: Ticlopidine Hydrochloride. | | | Inspected by local authority, Zhejiang Province Food and Drug Administration, on GMP compliance, and issued The “Drug Manufacturing Enterprise Licence” on Nov. 7, 2005. Licence No.: ZHE Ha20050650. The scope includes Ticlopidine Hydrochloride. | |
| |
